(ii) Cytogenetic lesions like those of the patients’ CLL clone (e.g., TP53 mutations, del 17p- or del 13q-) were not observed in the engrafted B cells. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.